got pregnant on tirzepatide and Pregnancy Mounjaro & Pregnancy: When to

Of note, in the recent consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), the use of GLP-1RAs with proven cardiovascular benefits should be preferred for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high risk

You will also have access to continuous support, ensuring that any questions or concerns you have are addressed promptly

Higher body weight may affect volume of distribution and drug exposure

Dosing tiers: Administer two to three hours before intended sleep time, not immediately at bedtime

Under the name brand Zepbound, tirzepatide is FDA-approved as a weight-loss treatment for patients with and without diabetes